Today’s announcement by Ahura Scientific corroborates comments that Andrew Whitley, a VP at Horiba Jobin-Yvon made earlier this week during SPIE’s Spectroscopy Technology + Applications conference. Presenting a breakdown of market share, Whitley noted that Ahura has acquired 10% share since it launched its first product just three years ago. Such growth, said Whitley, is all because of the increased need for portable and handheld spectrometers. That market segment is 25% at the moment, but growing 23% CAGR, he explained.
Today’s announcement by Ahura Scientific corroborates comments that Andrew Whitley, a VP at Horiba Jobin-Yvon made earlier this week during SPIE’s Spectroscopy Technology + Applications conference. Presenting a breakdown of market share, Whitley noted that Ahura has acquired 10% share since it launched its first product just three years ago. This growth, said Whitley, is all because of the increased need for portable and handheld spectrometers--a market segment that is 25% at the moment, but growing 23% CAGR.
Whitley also discussed the “huge potential for Raman” spectroscopy in the biomedical market—though he said the realization of that potential is probably still 15 to 20 years off.
William Yang, CEO of BaySpec, which also made an interesting announcement this week concerning portable spectroscopy, defined “portable” instrumentation as units that you can carry with two hands, and “handheld” devices as those that require only one hand for transport.
More information:
SPIE’s Spectroscopy Technology + Applications
Horiba Jobin-Yvon spectroscopy
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment